Safety, Tolerability and Pharmacokinetics of BEA 2180 BR in Healthy Male Volunteers

NCT02254720 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BEA 2180 BR solution for infusion
DRUG: Placebo
DRUG: BEA 2180 BR solution for inhalation
DEVICE: Respimat®

Sponsor

Boehringer Ingelheim